PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Biosimilars Gaining Traction as Regulator Confidence Grows

8 Winning Commercial Portfolio Strategies

Pharm Exec's 2017 Pipeline Report

Top Story
The Innovation Gap in Executive Compensation
How the need for biopharma innovation extends to questions around executive compensation.
By Carl Sjostrom and Ian Wilcox
/Read more/
Advertisement
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes. Learn more
Technology
Pharma Must Embrace Digital Transformation
However conservative and heavily regulated the drugs business, it too must transform itself to exploit digital opportunities — if only to ward off disruption, says Elvis Paćelat
/Read more/
Advertisement
Personalized medicine: Commercializing drugs with companion diagnostics
Live Webinar: Thursday, December 1 at 11:00 am EST
Register now
Europe
EMA Returns to the Fray on Adaptive Pathways
The European Medicine Association is determined keep open all options on the future of drug approvals in advance of a crucial meeting in December, writes Reflector
/Read more/
Advertisement
How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors
On Demand
Learn more
Global
Making NICE in Low and Middle Income Countries
Leela Barham speaks to NICE International and Imperial College’s Institute of Global Health Innovation about joining forces under the International Decision Support Initiative
/Read more/
ADVERTISEMENT
Calendar
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
/ February 08–09, 2017: Speaker Programs 2017 /
Philadelphia, PA
/ March 14–16, 2017: eyeforpharma Barcelona 2017 /
Barcelona, Spain
/ April 26–28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress /
Washington, DC
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
ADVERTISEMENT
 
Industry update
//Otonomy (San Diego, CA) appointed Kathie M. Bishop, Ph.D., as Chief Scientific Officer.//Nohla Therapeutics (Seattle, WA) appointed Dr. Shelly Heimfeld as Executive Vice President of Research and Manufacturing.//Albireo Pharma (Boston, MA) announced the appointment of Martha J. (Muffy) Carter as Chief Regulatory Officer.//Surefire Medical (Westminster, Colorado) announced that Mats Wahlström is joining the company's Board of Directors and will serve as Chairman.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com